Holmium: YAG laser system for transmyocardial revascularization

Expert Review of Medical Devices

Volumn 3, Issue 2, 2006, Pages 137-146

  Allen, Keith B ^a  

^a Department of Cardiothoracic Surgery   (United States)

Author keywords

Angina; Angiogenesis; CABG; Coronary artery disease; Ischemia; Laser

Indexed keywords

ANGINA PECTORIS; ANGIOGENESIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EXERCISE TOLERANCE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEART DENERVATION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HOLMIUM LASER; HUMAN; LASER SAFETY; LASER SURGERY; OUTCOMES RESEARCH; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; UNITED STATES; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; CLINICAL TRIALS; CORONARY DISEASE; EQUIPMENT DESIGN; HUMANS; LASER SURGERY; MYOCARDIAL REVASCULARIZATION; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33646183692     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.2.137     Document Type: Review

References (52)

1. Muhkerjee D, Bhatt D, Roe T, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis - how many patients might be eligible? Am. J. Cardiol. 84(5), 598-600 (1999).
2. Weintraub WS, Jones EL, Craver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am. J. Cardiol. 73, 103-112 (1994).
3. Allen KB, Dowling RD, Fudge TL et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N. Engl. J. Med. 341, 1029-1036 (1999).
4. Burkhoff D, Schmidt S, Schulman SP et al. Transmyocardial revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet 354, 885-890 (1999).
5. Allen KB, Dowling RD, Heimansohn DA, Reitsma E, Didelot G, Shaar CJ. Transmyocardial revascularization utilizing a holmium:YAG laser. Eur. J. Cardiothorac. Surg. 14(Suppl. 1), S100-S104 (1998).
6. Dowling RD, Petracek MR, Selinger SL, Allen KB. Transmyocardial revascularization in patients with refractory, unstable angina. Circulation 98(Suppl.), I173-I176 (1998).
7. Allen KB, Dowling R, DelRossi A et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J. Thorac. Cardiovasc. Surg. 119, 540-549 (2000).
8. Allen KB, Dowling RD, Angell W et al. Transmyocardial revascularization: five-year follow-up of a prospective, randomized, multicenter trial. Ann. Thorac. Surg. 77, 1228-1234 (2004).
9. Allen KB, Dowling RD, Schuch D et al. Adjunctive transmyocardial revascularization: 5-year follow-up of a prospective, randomized, trial. Ann. Thorac. Surg. 78, 458-465 (2004).
10. Kwong KF, Kanellopoulos GK, Nickols JC. Transmyocardial laser treatment denervates canine myocardium. J. Thorac. Cardiovasc. Surg. 114, 883-890 (1997).
11. Hirsch GM, Thompson GW, Arora RC, Hirsch KJ, Sullivan JA, Armour JA. Transmyocardial laser revascularization does not denervate the canine heart. Ann. Thorac. Surg. 68, 460-469 (1999).
12. Arora RC, Hirsch GM, Hirsch K, Armour JA. Transmyocardial laser revascularization remodels the intrinsic nervous system in a chronic setting. Circulation 104(Suppl.), I115-I120 (2001).
13. Minisi AJ, Topaz O, Quinn MS, Mohanty LB. Cardiac nociceptive reflexes after transmyocardial laser revascularization: implications for the neural hypothesis of angina relief. J. Thorac. Cardiovasc. Surg. 122, 712-719 (2001).
14. Hughes GC, Baklanov DV, Biswas SS et al. Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. J. Cardiovasc. Surg. 19, 21-27 (2004).
15. Al-Sheikh T, Allen KB, Straka SP et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation 100, 135-140 (1999).
16. Hughes GC, Kypson AP, St Louis JD. Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium. Ann. Thorac. Surg. 67, 1714-1720 (1999).
17. 123labeled meta-iodobenzylguanide scintigraphic evidence. J. Thorac. Cardiovasc. Surg. 127, 517-524 (2004).
18. 123labeled metaiodobenzylguanide scintigraphy in the assessment of transmyocardial laser revascularization. J. Thorac. Cardiovasc. Surg. 125, 1493-1498 (2003).
19. Myers J, Oesterle S, Jones J, Burkhoff D. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am. Heart J. 143, 1052-1057 (2002).
20. Yamamoto N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkhoff D. Transmyocardial revascularization enhances angiogenesis in a canine model of chronic ischemia. Circulation 31, 1426-1433 (1998).
21. Kohmoto T, DeRosa C, Yamamoto N et al. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann. Thorac. Surg. 65, 1360-1367 (1998).
22. Malekan R, Reynolds C, Narula N, Kelley ST, Suzuki Y, Bridges CR. Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury. Circulation 98, II62-II66 (1998).
23. 2, holmium and excimer lasers. Lasers Surg. Med. 35, 35-40 (2004).
24. Hughes GC, Lowe JE, Kypson AP et al. Neovascularization after transmyocardial revascularization in a model of chronic ischemia. Ann. Thorac. Surg. 66, 2029-2036 (1998).
25. 2, and excimer lasers. Ann. Thorac. Surg. 70, 504-509 (2000).
26. Hughes GC, Biswas SS, Yin B et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J. Am. Coll. Cardiol. 39(7), 1220-1228 (2002).
27. Muhling O, Wang Y, Jerosch-Herold M et al. Improved myocardial function after transmyocardial laser revascularization according to cine magnetic resonance in a porcine model. J Thorac. Cardiovasc. Surg. 128, 391-395 (2004).
28. Chu V, Giaid A, Kuang J et al. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures. Ann. Thorac. Surg. 42, 1-9 (1999).
29. Hughes GC, Lowe J. Revascularization versus denervation: what are the mechanisms of symptom relief? In: Myocardial Revascularization: Novel Percutaneous Approaches. Abela G (Ed.), Wiley-Liss, NY, USA, 63-79 (2002).
30. Domkowski PW, Biswas SS, Steenbergen C, Lowe JE. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization. Circulation 103, 469-471 (2001).
31. Holstrom M, Hanninen H, Simpanen J et al. Wall motion and perfusion analysis of transmyocardial laser revascularization. Scand. Cardiovasc. J. 37, 91-97 (2003).
32. Shroyer AL, Coombs LP, Peterson ED et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann. Thorac. Surg. 75, 1856-1865 (2003).
33. Allen KB, Shaar CJ. Transmyocardial laser revascularization as a clinical procedure. Letter to the editor. N. Engl. J. Med. 342, 438 (2000).
34. Gibbons R, Abrams J, Chatterjee K et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation 107, 149-158 (2002).
35. Bridges CR, Horvath KA, Nugent B et al. Society of Thoracic Surgeons Practice Guideline: transmyocardial laser revascularization. Ann. Thorac. Surg. 77, 1484-1502 (2004).
36. Allen KB, Dowling RD, Heimansohn DA et al. Transmyocardial revascularization utilizing a holmium:YAG laser. Eur. J. Cardiothorac. Surg. 14(Suppl. 1), S100-S104 (1998).
37. Osswald B, Blackstone E, Tochtermann U et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? Eur. J. Cardiothorac. Surg. 20, 120-126 (2001).
38. Graham MM, Chambers RJ, Davies RF. Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations. J. Thorac. Cardiovasc. Surg. 118, 618-627 (1999).
39. Schaff H, Gersh B, Pluth J et al. Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. Circulation 68(Suppl.), II200-II204 (1983).
40. Lawrie GM, Morris GC, Silvers A et al. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation 66, 717-723 (1982).
41. Bell MR, Gersh BJ, Schaff HV et al. Effect of completeness of revascularization on long-term outcomes of patients with three-vessel disease undergoing coronary artery bypass surgery. Circulation 86, 446-457 (1992).
42. DiMauro M, Iaco AL, Contini M et al. Reoperative coronary artery bypass grafting: analysis of early and late outcomes. Ann. Thorac. Surg. 79, 81-87 (2005).
43. Kleisi T, Cheng W, Jacobs MJ et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 129(6), 1283-1291 (2005).
44. Wehberg KE, Julian JS, Todd JC, Ogburn N, Klopp E, Buchness M. Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization. Heart Surg. Forum 6(5), 1-3 (2003).
45. Peterson ED, Kaul P, Kaczmarek RG et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J. Am. Coll. Cardiol. 42, 1611-1616 (2003).
46. Allen KB, Dowling RD, Richenbacher W. Letter to the editor. J. Am. Coll. Cardiol. 43(12), 2364-2365 (2004).
47. Horvath KA, Ferguson TB, Guyton RL. The Society of Thoracic Surgeons: statement submitted to the Medicare Coverage Advisory Committee, Centers of Medicare and Medicaid Services, regarding transmyocardial revascularization (2004).
48. Sayeed-Shah U, Reul RM, Byrne JG, Aranki SF, Cohn LH. Combination TMR and gene therapy. Semin. Thorac. Cardiovasc. Surg. 11(1), 36-39 (1999).
49. Hughes GC, Annex BH, Yin B et al. Transmyocardial laser revascularization limits in vivo adenoviral-mediated gene transfer in porcine myocardium. Cardiovasc. Res. 44(1), 81-90 (1999).
50. Heilmann CA, Altmann T, von Samson P et al. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up? Eur. J. Cardiothorac. Surg. 23(1), 74-78 (2003).
51. Klein HM, Ghodsizad A, Borowski A et al. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for patients with end-stage coronary heart disease: report on 2 cases. Heart Surg. Forum 7(5), E416-E419 (2004).
52. Horvath KA, Liu CYJ, Robert E et al. Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach. J. Thorac. Cardiovasc. Surg. 129(5), 1071-1077 (2005).